Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic insights into hypospadias in the Taiwanese population: A whole-exome sequencing study in a single center.

Journal of pediatric surgery·2026

Same author

CtBP1-LSD1 complex drives ErbB2 activation via H3K9me2 demethylation in DRGs during paclitaxel-induced neuropathic pain.

Cell biology and toxicology·2025

Same author

Tuning Multi-Wavelength Reflection Properties of Porous Silicon Bragg Reflectors Using Silver-Nanoparticle-Assisted Electrochemical Etching.

Micromachines·2025

Same author

Analysis and Identification of Genetic Predisposition and Clinical Risk Factors for Lung Cancer: A Regional Genetic Study.

Oncology·2025

Same author

The Association Between the Surgical Timing for Congenital Malformation of Lung and Asthma Prevalence-A Nationwide Cohort Study.

Pediatric pulmonology·2025

Same author

Atypical presentations and neurosurgical Synergy in the treatment of paravertebral tumors in children: Lessons from a single institution.

Pediatrics and neonatology·2025

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Castleman's disease mimicking intrapulmonary malignancy.

Chou Ming Yeh¹, Chia-Man Chou, Lai Ching Wong

¹Division of Thoracic Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.

The Annals of Thoracic Surgery

|July 24, 2007

Summary

Castleman's disease, a rare lymph node disorder, can present asymptomatically in the lungs. This case highlights intrapulmonary Castleman's disease mimicking lung cancer, successfully treated with surgery.

Related Experiment Videos

Last Updated: Jul 13, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Area of Science:

Oncology
Pulmonology
Pathology

Background:

Castleman's disease is a rare lymphoproliferative disorder affecting lymph nodes.
It typically manifests in the chest or abdomen, with peripheral involvement being less common.

Observation:

A 42-year-old male presented with an asymptomatic intrapulmonary mass.
The mass, identified as hyaline-vascular Castleman's disease, mimicked primary pulmonary malignancy.

Findings:

Surgical resection was curative for the intrapulmonary Castleman's disease.
Histopathological analysis confirmed the hyaline-vascular subtype.

Implications:

This case expands the differential diagnosis for intrapulmonary masses.
Early surgical intervention can lead to favorable outcomes for asymptomatic intrapulmonary Castleman's disease.